Ilaria Passalacqua,
Scientist, Process Development
Ilaria Passalacqua received her M.Sc. in Molecular and Industrial Biotechnology at the University of Pisa focusing her studies on CrispR-Cas9-mediated gene editing on melanoma cell lines. She carried out her PhD in Clinical Pathophysiology at University of Edinburgh and University of Pisa under the supervision of Prof. Baker at Queen’s Medical Research Institute. Her research explored the uptake of EVs in a Cre-LoxP engineered cell model of Pulmonary Arterial Hypertention. After her PhD graduation, she joined Exosomics to focus on single-EV characterization and developing innovative protocols and IP for the use of nano-flow cytometry on EV markers. Currently, she is Scientist II in Process Development Services group at Lonza Siena. In this role, Ilaria is using her knowledge and expertise on analytical and process development to support clients in their journey to bring EV-based therapies to patients.
|
|
|
